Evaluating Centene: Insights From 7 Financial Analysts
Portfolio Pulse from Benzinga Insights
Seven financial analysts have recently evaluated Centene (NYSE:CNC), showing a mix of somewhat bullish and indifferent ratings, with no bullish or bearish stances. The average 12-month price target for CNC is set at $91.00, slightly down from the previous $91.40. Analyst actions include both raises and lowers in ratings and price targets, reflecting adjustments to market conditions and Centene's performance. Centene, a managed-care organization, has shown positive revenue growth and strong financial metrics, including net margin and ROE, but carries a higher debt-to-equity ratio than industry averages.

April 15, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Centene receives mixed analyst ratings with a slight decrease in the average price target to $91.00. The company's strong financial performance and growth metrics may influence its stock positively.
The mixed analyst ratings reflect a cautious but somewhat positive outlook on Centene, with the slight decrease in the average price target suggesting minor concerns. However, Centene's strong financial performance, including revenue growth and profitability metrics, alongside its strategic position in the healthcare sector, could counterbalance concerns and lead to positive stock performance in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100